Novel Analgesics for the Treatment of Bone Cancer Pain

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$109,305.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43CA110524-01
Agency Tracking Number:
CA110524
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
ST. CHARLES PHARMACEUTICALS
ST. CHARLES PHARMACEUTICALS, PO BOX 850616, NEW ORLEANS, LA, 70185
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 ANTHONY Vaccarino
 (504) 280-6771
 AVACCARI@STCHARLESPHARMA.COM
Business Contact
 KENNETH NARDUCY
Phone: () -
Email: KNARDUCY@MSN.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Pain is the most prevalent symptom in cancer patients, and bone metastasis is one of the most common sources of cancer-related pain. In the 3-step guidelines established by the World Health Organization (WHO) non-opioi

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government